Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hiiti B. Sillo"'
Autor:
Alireza Khadem Broojerdi, Anna Laura Salvati, Mohammed Refaat Abdelfattah, Razieh Ostad Ali Dehaghi, Hiiti B. Sillo, Rogerio Gaspar
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundIncreased global access to safe, effective and quality-assured medical products remains a primary goal for the full realization of the World Health Assembly Resolution WHA 67.20 on regulatory systems strengthening for medical products as we
Externí odkaz:
https://doaj.org/article/8976e2a52075414296b749f4f3b17e2b
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionTraining opportunities for health product regulators are among the critical aspects in the strengthening of regulatory systems across the world. The need for training is reasonably higher among the National Regulatory Agencies (NRAs) in t
Externí odkaz:
https://doaj.org/article/09adc0e2ff8a455dbd09077d76d18525
Autor:
Adam M Fimbo, Hiiti B Sillo, Alex Nkayamba, Sunday Kisoma, Yonah Hebron Mwalwisi, Rafiu Idris, Sarah Asiimwe, Patrick Githendu, Osondu Ogbuoji, Linden Morrison, Jesse B Bump, Eliangiringa Kaale
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 10, p e0003241 (2024)
Improving medicines regulation can lead to better population health, but how this process works in low- and middle-income countries remains underexplored. Tanzania's pharmaceutical sector is often cited as a successful example of a well-functioning r
Externí odkaz:
https://doaj.org/article/37c42cdc596142d182c8ba61efde25a8
Autor:
Hiiti B Sillo, Nelson E Masota, Sunday Kisoma, Lembit Rago, Veronica Mgoyela, Eliangiringa A Kaale
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0197490 (2018)
BACKGROUND:Availability of correct and adequate information about medicines is an important aspect in ensuring rational use of medicines and hence facilitating safety and expected efficacy of medicines during therapy. Package inserts have proven to b
Externí odkaz:
https://doaj.org/article/2c04d1a70adb469eb98235687edbf916
Publikováno v:
Antiviral therapy. 19
Medicines of uncertain quality, safety and efficacy can be worse than no treatment at all. It is the responsibility of national medicines regulatory authorities to protect patients from harm. Yet, there are great disparities in regulatory capacity gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333304720b2dda15d7c2ba82446b9ebd
https://pubmed.ncbi.nlm.nih.gov/25310085
https://pubmed.ncbi.nlm.nih.gov/25310085
Publikováno v:
Journal of Public Health Policy, 35(2), 137-161. PALGRAVE MACMILLAN LTD
Problems with the quality of medicines abound in countries where regulatory and legal oversight are weak, where medicines are unaffordable to most, and where the official supply often fails to reach patients. Quality is important to ensure effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37531806723174f5444ad7a12d08e737
https://pubmed.ncbi.nlm.nih.gov/24430804
https://pubmed.ncbi.nlm.nih.gov/24430804